BTIG Maintains Buy on DexCom, Lowers Price Target to $105

BTIG analyst Marie Thibault maintains DexCom (NASDAQ:DXCM) with a Buy and lowers the price target from $135 to $105.

BTIG analyst Marie Thibault maintains DexCom (NASDAQ:DXCM) with a Buy and lowers the price target from $135 to $105.

Total
0
Shares
Related Posts